Cellectar Biosciences
CLRB
CLRB
8 hedge funds and large institutions have $597K invested in Cellectar Biosciences in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$58.8K | |
| 2 | +$53K | |
| 3 | +$24K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4K |
Top Sellers
| 1 | -$43K | |
| 2 | -$41K | |
| 3 | -$29K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$19.8K |
| 5 |
Morgan Stanley
New York
|
-$5.33K |